Recombinant Protein leading To Cardiac Pressure

rbprotein

 

Glycolaldehyde-Modified proteins trigger adversarial practical and structural aortic reworking resulting in cardiac strain overload

Rising proof helps the position of superior glycation finish merchandise (AGEs) within the growth of diabetic vascular problems and cardiovascular illnesses (CVDs). We now have proven that high-molecular-weight AGEs (HMW-AGEs), current in our Western eating regimen, impair cardiac perform. Whether or not HMW-AGEs have an effect on vascular perform stays unknown.

On this research, we aimed to research the affect of continual HMW-AGEs publicity on vascular perform and construction. Grownup male Sprague Dawley rats had been each day injected with HMW-AGEs or management resolution for six weeks. HMW-AGEs animals confirmed intracardiac strain overload, characterised by elevated systolic and imply pressures.

The contraction response to PE was elevated in aortic rings from the HMW-AGEs group. Leisure in response to ACh, however not SNP, was impaired by HMW-AGEs. This was related to decreased plasma cyclic GMP ranges. SOD restored ACh-induced leisure of HMW-AGEs animals to manage ranges, accompanied by a decreased half-maximal efficient dose (EC50).

 

rbprotein
rbprotein

Lastly, collagen deposition and intima-media thickness of the aortic vessel wall had been elevated with HMW-AGEs. Our knowledge show that continual HMW-AGEs publicity causes adversarial vascular remodelling. That is characterised by disturbed vasomotor perform attributable to elevated oxidative stress and structural modifications within the aorta, suggesting an vital contribution of HMW-AGEs within the growth of CVDs.

 

PRDM1 Recombinant Protein (Human)

Giant-scale, unbiased proteomics research are constrained by the complexity of the plasma proteome. Right here we report a extremely parallel protein quantitation platform integrating nanoparticle (NP) protein coronas with liquid chromatography-mass spectrometry for environment friendly proteomic profiling. A protein corona is a protein layer adsorbed onto NPs upon contact with biofluids.

Various the physicochemical properties of engineered NPs interprets to distinct protein corona patterns enabling differential and reproducible interrogation of organic samples, together with deep sampling of the plasma proteome. Spike experiments verify a linear sign response.

The median coefficient of variation was 22%. We screened 43 NPs and chosen a panel of 5, which detect greater than 2,000 proteins from 141 plasma samples utilizing a 96-well automated workflow in a pilot non-small cell lung most cancers classification research.

Our streamlined workflow combines depth of protection and throughput with exact quantification based mostly on distinctive interactions between proteins and NPs engineered for deep and scalable quantitative proteomic research.

 

Polyclonal BLIMP1 / PRDM1 Antibody (Inside)

Description: A polyclonal antibody raised in Goat that acknowledges and binds to Human BLIMP1 / PRDM1 (Inside). This antibody is examined and confirmed to work within the following purposes:

 

 

    • Bcl-2 inhibitors show an efficient exercise in acute myeloid leukemia (AML), however its scientific efficacy as a monotherapy was restricted partially owing to failure to focus on different antiapoptotic Bcl-2 household proteins, akin to Mcl-1.

 

    • On this context, the mixture technique could also be a promising strategy to beat this barrier. Right here, we report the preclinical efficacy of a novel technique combining ABT-199 with triptolide (TPL), a pure product extracted from a standard Chinese language medication, in AML.

 

    • Mixture therapy exhibited markedly elevated cytotoxicity in leukemic cells regardless of p53 standing whereas largely sparing regular cells of the hematopoietic lineage. Furthermore, co-administration of ABT-199 with TPL dramatically suppressed leukemia development in addition to extended animal survival in a xenograft AML mannequin.

 

    • The potentiated impact of ABT-199 and TPL towards AML was related to activation of the mitochondrum-related intrinsic apoptotic pathway by a mechanism reciprocally modulating Bcl-2 household proteins. On this case, TPL not solely downregulated Mcl-1 but additionally upregulated proapoptotic BH3-only proteins, thereby overcoming the resistance towards ABT-199.

 

    • Conversely, ABT-199 abrogated Bcl-2-mediated cytoprotection towards TPL. Collectively, these findings recommend that the routine combining TPL and ABT-199 may be energetic towards AML by inducing sturdy apoptosis by reciprocal regulation of anti- and proapoptotic Bcl-2 household proteins, due to this fact offering a powerful rationale for the scientific investigation of this mixture routine for the therapy of AML.

 

 

PRDM1

MBS8564862-01mL 0.1mL
EUR 345

PRDM1

MBS8564862-01mLAF405L 0.1mL(AF405L)
EUR 565

PRDM1

MBS8564862-01mLAF405S 0.1mL(AF405S)
EUR 565

PRDM1

MBS8564862-01mLAF610 0.1mL(AF610)
EUR 565

PRDM1

MBS8564862-01mLAF635 0.1mL(AF635)
EUR 565

PRDM1 siRNA

20-abx929665
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

PRDM1 siRNA

20-abx929666
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

PRDM1 Peptide

42-727P 0.1 mg
EUR 405.6
Description: (CT) PRDM1 / BLIMP1 peptide

PRDM1 Peptide

42-784P 0.1 mg
EUR 405.6
Description: (IN) PRDM1 / MEL1 peptide

PRDM1 Peptide

MBS3228823-01mg 0.1mg
EUR 180

PRDM1 Peptide

MBS3228823-5x01mg 5x0.1mg
EUR 730

PRDM1 antibody

10R-2174 100 ul
EUR 468
Description: Mouse monoclonal PRDM1 antibody

PRDM1 Antibody

48403 100ul
EUR 429

PRDM1 Antibody

48403-100ul 100ul
EUR 399.6

PRDM1 Antibody

48403-50ul 50ul
EUR 286.8

PRDM1 Antibody

E10-30020 100μg/100μl
EUR 225
Description: Available in various conjugation types.

PRDM1 Antibody

E307250 100ug/200ul
EUR 275
Description: Available in various conjugation types.

PRDM1 Antibody

CSB-PA193485- each
EUR 402
Description: A polyclonal antibody against PRDM1. Recognizes PRDM1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000

PRDM1 Antibody

CSB-PA193485-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against PRDM1. Recognizes PRDM1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000

PRDM1 Antibody

GWB-MX442A 50ug Ask for price

PRDM1 Antibody

GWB-6A40F0 0.1 mg Ask for price

PRDM1 Antibody

R34682-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: PR domain containing 1, RP1-134E15.1, BLIMP1

PRDM1 Antibody

R33488-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: PR domain containing 1

PRDM1 antibody

BF0254 100ug
EUR 355

PRDM1 Antibody

MBS7130543-01mL 0.1mL
EUR 270

PRDM1 Antibody

MBS7130543-5x01mL 5x0.1mL
EUR 1200

PRDM1 Antibody

MBS8502808-01mg 0.1mg
EUR 345

PRDM1 Antibody

MBS8502808-01mLAF405L 0.1mL(AF405L)
EUR 565

PRDM1 Antibody

MBS8502808-01mLAF405S 0.1mL(AF405S)
EUR 565

PRDM1 Antibody

MBS8502808-01mLAF610 0.1mL(AF610)
EUR 565

PRDM1 Antibody

MBS8502808-01mLAF635 0.1mL(AF635)
EUR 565

PRDM1 Antibody

MBS850393-01mg 0.1mg
EUR 305

PRDM1 Antibody

MBS850393-01mLAF405L 0.1mL(AF405L)
EUR 565

PRDM1 Antibody

MBS850393-01mLAF405S 0.1mL(AF405S)
EUR 565

PRDM1 Antibody

MBS850393-01mLAF610 0.1mL(AF610)
EUR 565

PRDM1 Antibody

MBS850393-01mLAF635 0.1mL(AF635)
EUR 565

PRDM1 antibody

MBS533232-01mL 0.1mL
EUR 810

PRDM1 antibody

MBS533232-5x01mL 5x0.1mL
EUR 3505

PRDM1 Antibody

MBS9435257-005mL 0.05mL
EUR 325

PRDM1 Antibody

MBS9435257-01mL 0.1mL
EUR 445

PRDM1 Antibody

MBS9435257-5x01mL 5x0.1mL
EUR 1860

PRDM1 Antibody

BF0254-100ul 100ul
EUR 210
Description: WB,ELISA

PRDM1 Antibody

BF0254-200ul 200ul Ask for price
Description: WB,ELISA

PRDM1 Antibody

BF0254-50ul 50ul
EUR 150
Description: WB,ELISA

PRDM1 Mouse mAb

E2220394 100ul
EUR 225
Description: Available in various conjugation types.

PRDM1 Mouse mAb

E2222673 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

PRDM1 Mouse mAb

MBS8538604-01mL 0.1mL
EUR 305

PRDM1 Mouse mAb

MBS8538604-01mLAF405L 0.1mL(AF405L)
EUR 565

PRDM1 Mouse mAb

MBS8538604-01mLAF405S 0.1mL(AF405S)
EUR 565

PRDM1 Mouse mAb

MBS8538604-01mLAF610 0.1mL(AF610)
EUR 565

PRDM1 Mouse mAb

MBS8538604-01mLAF635 0.1mL(AF635)
EUR 565

PRDM1 Rabbit pAb

A1960-100ul 100 ul
EUR 369.6

PRDM1 Rabbit pAb

A1960-200ul 200 ul
EUR 550.8

PRDM1 Rabbit pAb

A1960-20ul 20 ul
EUR 219.6

PRDM1 Rabbit pAb

A1960-50ul 50 ul
EUR 267.6

PRDM1 cDNA Clone

MBS1270137-001mgPlasmid02mLGlycerolStock 0.01mgPlasmid+0.2mLGlycerol-Stock
EUR 435

PRDM1 cDNA Clone

MBS1270137-5x001mgPlasmid5x02mLGlycerolStock 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock
EUR 1910

PRDM1 Rabbit pAb

A1960 1000μL
EUR 173.58

PRDM1 siRNA (Mouse)

MBS8203960-15nmol 15nmol
EUR 405

PRDM1 siRNA (Mouse)

MBS8203960-30nmol 30nmol
EUR 565

PRDM1 siRNA (Mouse)

MBS8203960-5x30nmol 5x30nmol
EUR 2450

PRDM1 siRNA (Human)

MBS8227348-15nmol 15nmol
EUR 405

PRDM1 siRNA (Human)

MBS8227348-30nmol 30nmol
EUR 565

PRDM1 siRNA (Human)

MBS8227348-5x30nmol 5x30nmol
EUR 2450

PRDM1 cloning plasmid

CSB-CL018638HU-10ug 10ug
EUR 568.8
Description: A cloning plasmid for the PRDM1 gene.

PRDM1 Antibody / BLIMP1

RQ4227 100 ug
EUR 356.15
Description: PR domain zinc finger protein 1, also known as B Lymphocyte Induced Maturation Protein 1 (BLIMP-1), is a protein that in humans is encoded by the PRDM1 gene. This gene encodes a protein that acts as a repressor of beta-interferon gene expression. The protein binds specifically to the PRDI (positive regulatory domain I element) of the beta-IFN gene promoter. Transcription of this gene increases upon virus induction. Two alternatively spliced transcript variants that encode different isoforms have been reported.

PRDM1 Antibody / BLIMP1

V5177-100UG 100ug
EUR 363.3
Description: The development and differentiation of plasma cells, which are terminally differentiated B-cells, are induced by Blimp-1 (B lymphocyte-induced maturation protein, also designated PRDI-BF1). Blimp-1 is a transcriptional repressor that localizes to the nucleus and is considered a master regulator of terminal B-cell development. Alone, Blimp-1 is sufficient to trigger terminal B-cell differentiation. Blimp-1 upregulates the expression of syndecan-1 and J chain, represses IFN-b gene transcription and associates with HDAC to recruit it to DNA, thereby repressing c-Myc. Blimp-1 is expressed during the late stages of B-cell differentiation in immunoglobulin-secreting plasma cells, as well as in long-lived, bone marrow plasma cells. The expression of Blimp-1 defines a checkpoint beyond which fully activated B cells proceed to the plasma cell stage, whereas immature and partially activated cells are eliminated.

PRDM1 Antibody / BLIMP1

V5177-20UG 20ug
EUR 160.3
Description: The development and differentiation of plasma cells, which are terminally differentiated B-cells, are induced by Blimp-1 (B lymphocyte-induced maturation protein, also designated PRDI-BF1). Blimp-1 is a transcriptional repressor that localizes to the nucleus and is considered a master regulator of terminal B-cell development. Alone, Blimp-1 is sufficient to trigger terminal B-cell differentiation. Blimp-1 upregulates the expression of syndecan-1 and J chain, represses IFN-b gene transcription and associates with HDAC to recruit it to DNA, thereby repressing c-Myc. Blimp-1 is expressed during the late stages of B-cell differentiation in immunoglobulin-secreting plasma cells, as well as in long-lived, bone marrow plasma cells. The expression of Blimp-1 defines a checkpoint beyond which fully activated B cells proceed to the plasma cell stage, whereas immature and partially activated cells are eliminated.

PRDM1 Antibody / BLIMP1

V5177SAF-100UG 100ug
EUR 363.3
Description: The development and differentiation of plasma cells, which are terminally differentiated B-cells, are induced by Blimp-1 (B lymphocyte-induced maturation protein, also designated PRDI-BF1). Blimp-1 is a transcriptional repressor that localizes to the nucleus and is considered a master regulator of terminal B-cell development. Alone, Blimp-1 is sufficient to trigger terminal B-cell differentiation. Blimp-1 upregulates the expression of syndecan-1 and J chain, represses IFN-b gene transcription and associates with HDAC to recruit it to DNA, thereby repressing c-Myc. Blimp-1 is expressed during the late stages of B-cell differentiation in immunoglobulin-secreting plasma cells, as well as in long-lived, bone marrow plasma cells. The expression of Blimp-1 defines a checkpoint beyond which fully activated B cells proceed to the plasma cell stage, whereas immature and partially activated cells are eliminated.

PRDM1 Blocking Peptide

BF0254-BP 1mg
EUR 234

PRDM1 Blocking Peptide

MBS9619957-1mg 1mg
EUR 380

 

 

Monoclonal PRDM1 Antibody (monoclonal) (M01), Clone: 2B10

Description: A Monoclonal antibody towards Human PRDM1 (monoclonal) (M01). The antibodies are raised in mouse and are from clone 2B10. This antibody is relevant in WB, E

Aptamer-directed Protein-specific A number of Modifications of Membrane Glycoproteins on Dwelling Cells

Understanding how a cell membrane protein capabilities on dwelling cells stays a problem for cell biology. Particular placement of practical molecules on particular proteins of their native atmosphere would enable complete research of proteins’ dynamic capabilities.

Present strategies can’t facilely obtain a number of modifications on particular membrane proteins. On this report, we describe an aptamer-induced, protein-specific bioorthogonal modification expertise for exact non-genetic immobilization of a number of small practical molecules heading in the right direction membrane glycoproteins by combining metabolic expertise and aptamer focusing on.

In briefly, DNA probes had been designed by modifying aptamers, which bind to focus on proteins on the surfaces of dwelling cells pretreated with N-azidoacetylmannosamine-tetraacylated (Ac4ManNAz). The cyclooctynes tagged of DNA probes will strategy the azide teams to set off the bioorthogonal reactions.

After UV irradiation and hybridization with cDNA (complementary DNA), the aptamers will be eliminated, and the method will be repeated to attain a number of modifications for multicolor imaging and cell floor nano-engineering on particular proteins.

 

Phospho-Amyloid-Beta (T743) Polyclonal Antibody

BT-PHS00855-20ul 20ul Ask for price
Description: APP encodes a cell surface receptor and transmembrane precursor protein (amyloid beta precursor protein) that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in APP have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for APP.

Phospho-Amyloid-Beta (T743) Polyclonal Antibody

BT-PHS00855-50ul 50ul Ask for price
Description: APP encodes a cell surface receptor and transmembrane precursor protein (amyloid beta precursor protein) that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in APP have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for APP.

Phospho-Amyloid-beta (T743) Polyclonal Antibody

MBS2534999-002mL 0.02mL
EUR 140

Phospho-Amyloid-beta (T743) Polyclonal Antibody

MBS2534999-006mL 0.06mL
EUR 180

Phospho-Amyloid-beta (T743) Polyclonal Antibody

MBS2534999-012mL 0.12mL
EUR 260

Phospho-Amyloid-beta (T743) Polyclonal Antibody

MBS2534999-02mL 0.2mL
EUR 405

Phospho-Amyloid-beta (T743) Polyclonal Antibody

MBS2534999-5x02mL 5x0.2mL
EUR 1725

Anti-Phospho-Amyloid-beta (T743) APP Antibody

A00081T743 100ul
EUR 380
Description: Boster Bio Anti-Phospho-Amyloid-beta (T743) APP Antibody catalog # A00081T743. Tested in ELISA, IF, IHC, WB applications. This antibody reacts with Human, Mouse, Rat.

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (AP)

MBS6406894-01mL 0.1mL
EUR 950

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (AP)

MBS6406894-5x01mL 5x0.1mL
EUR 4120

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (APC)

MBS6406895-01mL 0.1mL
EUR 950

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (APC)

MBS6406895-5x01mL 5x0.1mL
EUR 4120

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (HRP)

MBS6406898-01mL 0.1mL
EUR 950

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (HRP)

MBS6406898-5x01mL 5x0.1mL
EUR 4120

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (PE)

MBS6406904-01mL 0.1mL
EUR 950

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (PE)

MBS6406904-5x01mL 5x0.1mL
EUR 4120

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (FITC)

MBS6406897-01mL 0.1mL
EUR 950

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (FITC)

MBS6406897-5x01mL 5x0.1mL
EUR 4120

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (Biotin)

MBS6406896-01mL 0.1mL
EUR 950

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (Biotin)

MBS6406896-5x01mL 5x0.1mL
EUR 4120

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (MaxLight 405)

MBS6406899-01mL 0.1mL
EUR 950

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (MaxLight 405)

MBS6406899-5x01mL 5x0.1mL
EUR 4120

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (MaxLight 490)

MBS6406900-01mL 0.1mL
EUR 950

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (MaxLight 490)

MBS6406900-5x01mL 5x0.1mL
EUR 4120

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (MaxLight 550)

MBS6406901-01mL 0.1mL
EUR 950

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (MaxLight 550)

MBS6406901-5x01mL 5x0.1mL
EUR 4120

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (MaxLight 650)

MBS6406902-01mL 0.1mL
EUR 950

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (MaxLight 650)

MBS6406902-5x01mL 5x0.1mL
EUR 4120

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (MaxLight 750)

MBS6406903-01mL 0.1mL
EUR 950

APP, Phosphorylated (T743) (Amyloid Precursor Protein, AAA, AD1, PN2, ABPP, APPI, CVAP, ABETA, PN-II, CTFgamma) (MaxLight 750)

MBS6406903-5x01mL 5x0.1mL
EUR 4120

Phospho-APP-T743 Polyclonal Antibody

MBS125591-002mL 0.02mL
EUR 220

Phospho-APP-T743 Polyclonal Antibody

MBS125591-005mL 0.05mL
EUR 295

Phospho-APP-T743 Polyclonal Antibody

MBS125591-01mL 0.1mL
EUR 430

Phospho-APP-T743 Polyclonal Antibody

MBS125591-02mL 0.2mL
EUR 600

Phospho-APP-T743 Polyclonal Antibody

MBS125591-5x02mL 5x0.2mL
EUR 2525

T0070907 (T-0070907; T 0070907)

MBS131456-100mg 100mg
EUR 1495

CHC_T00008727001 Antibody

PHY6394S 150 μg
EUR 289

T0070907

2095-5 each
EUR 216

T-5342126

464825 1.0mg
EUR 230

T0070907

406129 10.0mg
EUR 90

T0901317

B1636-25 each
EUR 457.2

T0901317

B1636-5 each
EUR 164.4

T5601640

B1097-1 each
EUR 157.2

T5601640

B1097-5 each
EUR 444

T0070907

A4301-10 10 mg
EUR 40
Description: Human PPARγ antagonist,potent and selective

T0070907

A4301-25 25 mg
EUR 96
Description: Human PPARγ antagonist,potent and selective

T0070907

A4301-5.1 10 mM (in 1mL DMSO)
EUR 40
Description: Human PPARγ antagonist,potent and selective

T0070907

A4301-50 50 mg
EUR 152
Description: Human PPARγ antagonist,potent and selective

T-5601640

562706 25.0mg
EUR 350

T6167923

563472 10.0mg
EUR 235

T-0901317

558247 10.0mg
EUR 100

T0901317

A2249-100 100 mg
EUR 136
Description: Liver X receptor agonist,potent and selective

T0901317

A2249-25 25 mg
EUR 48
Description: Liver X receptor agonist,potent and selective

T0901317

A2249-5.1 10 mM (in 1mL DMSO)
EUR 48
Description: Liver X receptor agonist,potent and selective

T-5342126

T35864-10mg 10mg Ask for price
Description: T-5342126

T-5342126

T35864-1g 1g Ask for price
Description: T-5342126

T-5342126

T35864-1mg 1mg Ask for price
Description: T-5342126

T-5342126

T35864-50mg 50mg Ask for price
Description: T-5342126

T-5342126

T35864-5mg 5mg Ask for price
Description: T-5342126

T6167923

T966338 100mg
EUR 293
Description: 1090528-71-4

T0901317

GL6126 10mg
EUR 154.78

T0070907

HY-13202 10mM/1mL
EUR 135.6

T6167923

HY-19744 5mg
EUR 831.6

T0901317

HY-10626 100mg
EUR 325.2

T0901317

GL6126-10 10
EUR 74.7

T0901317

GL6126-50 50
EUR 169

T-3256336

T26246-10mg 10mg Ask for price
Description: T-3256336

T-3256336

T26246-1g 1g Ask for price
Description: T-3256336

T-3256336

T26246-1mg 1mg Ask for price
Description: T-3256336

T-3256336

T26246-50mg 50mg Ask for price
Description: T-3256336

T-3256336

T26246-5mg 5mg Ask for price
Description: T-3256336

T-1840383

T28899-10mg 10mg Ask for price
Description: T-1840383

T-1840383

T28899-1g 1g Ask for price
Description: T-1840383

T-1840383

T28899-1mg 1mg Ask for price
Description: T-1840383

T-1840383

T28899-50mg 50mg Ask for price
Description: T-1840383

T-1840383

T28899-5mg 5mg Ask for price
Description: T-1840383

T-3364366

T28903-10mg 10mg Ask for price
Description: T-3364366

T-3364366

T28903-1g 1g Ask for price
Description: T-3364366

T-3364366

T28903-1mg 1mg Ask for price
Description: T-3364366

Leave A Comment